Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity - A Phase 2 Trial. Jastreboff AM, Ryan DH, Bays HE, Ebeling PR, et al. N Engl J Med 2025 Jun 23. doi: 10.1056/NEJMoa2504214.

Read + Share

Amedeo Smart

Independent Medical Education

Jastreboff AM, Ryan DH, Bays HE, Ebeling PR, et al. Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity - A Phase 2 Trial. N Engl J Med 2025 Jun 23. doi: 10.1056/NEJMoa2504214.
PMID: 40549887